Zhongmin Maxwell Wang

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as eerstelijns treatment for gevorderd squamous n...

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blin...

Ivonescimab plus chemotherapie bij EGFR-variant NSCLC: fase II